METHOD OF TREATMENT OF LINGERING RELAPSING FORMS OF TUBERCULOSIS AND ITS SPECIFIC COMPLICATIONS IN CHILDREN

摘要

FIELD: medicine, infectious diseases, pediatrics. SUBSTANCE: method involves administration of recombinant human interleukin-2, roncoleukin, in the dose from 10 000 to 40 000 IU per 24 h by parenteral route in the dose from 10 000 to 15 000 per 24 h and by oral route in the dose from 20 000 to 40 000 IU per 24 h. Invention provides decrease of intoxication and periods of relapse symptoms duration and can be used for treatment of lingering relapsing forms of tuberculosis in children. EFFECT: improved and enhanced method of treatment. 3 cl, 3 tbl, 5 ex